HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early mediastinal seroma secondary to modified Blalock-Taussig shunts--successful management by percutaneous drainage.

AbstractBACKGROUND:
Large symptomatic mediastinal seroma following modified-BT shunts, traditionally required revisional thoracotomy.
OBJECTIVE:
We describe percutaneous image-guided pigtail catheter drainage in the successful treatment of early mediastinal seroma secondary to PTFE Blalock-Taussig shunt, avoiding thoracotomy.
MATERIALS AND METHODS:
A retrospective review of all relevant clinical and imaging records in five patients was performed.
RESULTS:
All five presented with intermittent stridor, respiratory distress and/or episodic desaturation within 6 weeks of their surgery. In four of five infants, percutaneous drainage was effective and reoperation was avoided. In one of five, rather than urgent surgical evacuation and BT shunt revision, we were able to perform an elective stage-II bidirectional Glenn SVC-RA anastamosis in a stable infant. There were no complications.
CONCLUSIONS:
Percutaneous image-guided drainage of mediastinal seroma secondary to PTFE-BT shunt is a safe, minimally invasive, and effective treatment. This may avoid BT shunt revision.
AuthorsBairbre L Connolly, Michael J Temple, Peter G Chait, Ricardo Restrepo, Ian Adatia
JournalPediatric radiology (Pediatr Radiol) Vol. 33 Issue 7 Pg. 495-8 (Jul 2003) ISSN: 0301-0449 [Print] Germany
PMID12682792 (Publication Type: Journal Article)
Chemical References
  • Polytetrafluoroethylene
Topics
  • Cardiac Surgical Procedures (adverse effects)
  • Drainage (methods)
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Mediastinal Diseases (etiology, therapy)
  • Polytetrafluoroethylene
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: